_version_ 1784813343406555136
author Nishikimi, Akihiko
Nakagawa, Takeshi
Fujiwara, Mitsuhiro
Watanabe, Ken
Watanabe, Atsushi
Komatsu, Ayane
Yasuoka, Mikako
Watanabe, Ryota
Naya, Masahiro
Oshima, Hironori
Kitagawa, Yuichi
Tokuda, Haruhiko
Kondo, Izumi
Niida, Shumpei
Sakurai, Takashi
Kojima, Masayo
Arai, Hidenori
author_facet Nishikimi, Akihiko
Nakagawa, Takeshi
Fujiwara, Mitsuhiro
Watanabe, Ken
Watanabe, Atsushi
Komatsu, Ayane
Yasuoka, Mikako
Watanabe, Ryota
Naya, Masahiro
Oshima, Hironori
Kitagawa, Yuichi
Tokuda, Haruhiko
Kondo, Izumi
Niida, Shumpei
Sakurai, Takashi
Kojima, Masayo
Arai, Hidenori
author_sort Nishikimi, Akihiko
collection PubMed
description
format Online
Article
Text
id pubmed-9584759
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-95847592022-10-21 Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan Nishikimi, Akihiko Nakagawa, Takeshi Fujiwara, Mitsuhiro Watanabe, Ken Watanabe, Atsushi Komatsu, Ayane Yasuoka, Mikako Watanabe, Ryota Naya, Masahiro Oshima, Hironori Kitagawa, Yuichi Tokuda, Haruhiko Kondo, Izumi Niida, Shumpei Sakurai, Takashi Kojima, Masayo Arai, Hidenori J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-02 2022-10-21 /pmc/articles/PMC9584759/ /pubmed/36273645 http://dx.doi.org/10.1016/j.jinf.2022.10.026 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Nishikimi, Akihiko
Nakagawa, Takeshi
Fujiwara, Mitsuhiro
Watanabe, Ken
Watanabe, Atsushi
Komatsu, Ayane
Yasuoka, Mikako
Watanabe, Ryota
Naya, Masahiro
Oshima, Hironori
Kitagawa, Yuichi
Tokuda, Haruhiko
Kondo, Izumi
Niida, Shumpei
Sakurai, Takashi
Kojima, Masayo
Arai, Hidenori
Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan
title Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan
title_full Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan
title_fullStr Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan
title_full_unstemmed Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan
title_short Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan
title_sort humoral and cellular responses to the third covid-19 bnt162b2 vaccine dose in research institute workers in japan
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584759/
https://www.ncbi.nlm.nih.gov/pubmed/36273645
http://dx.doi.org/10.1016/j.jinf.2022.10.026
work_keys_str_mv AT nishikimiakihiko humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT nakagawatakeshi humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT fujiwaramitsuhiro humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT watanabeken humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT watanabeatsushi humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT komatsuayane humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT yasuokamikako humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT watanaberyota humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT nayamasahiro humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT oshimahironori humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT kitagawayuichi humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT tokudaharuhiko humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT kondoizumi humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT niidashumpei humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT sakuraitakashi humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT kojimamasayo humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan
AT araihidenori humoralandcellularresponsestothethirdcovid19bnt162b2vaccinedoseinresearchinstituteworkersinjapan